Laura Burns, MD

Article

Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect

Author:

Kaitlin Blankenship, MD

Laura Burns, MD

Mark Scharf, MD

Vedolizumab, a monoclonal antibody for the treatment of refractory inflammatory bowel disease, was found to cause acne fulminans without systemic...

• Read More